What's Behind The Jump In Vor Biopharma Stock?

Vor Biopharma stock is among today’s top performers. What’s driving VOR stock higher?Vor Biopharma To Raise $75 Million Through Private PlacementThe clinical-stage biotechnology company entered into a securities purchase agreement to sell 5,338,078 shares of its common stock at $14.05 per share. Vor Bio anticipates the gross proceeds from the private placement to be approximately $75 million, before deducting any offering-related expenses. The private placement is expected to close on or about March 30. Ene ...